상세 보기
Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04
- Ahn, Jin Seok;
- Ahn, Yong Chan;
- Kim, Joo-Hang;
- Lee, Chang Geol;
- Cho, Eun Kyung;
- ... Choi, Yoon-La;
- ... Sun, Jong-Mu;
- 외 16명
WEB OF SCIENCE
208SCOPUS
243초록
Purpose To determine the efficacy of consolidation chemotherapy (CC) with docetaxel and cisplatin (DP) after concurrent chemoradiotherapy (CCRT) with the same agents in locally advanced non-small-cell lung cancer (LA-NSCLC). Patient and Methods Patients were randomly assigned to either CCRT alone (observation arm) or CCRT followed by CC (consolidation arm). CCRT with docetaxel (20 mg/m(2)) and cisplatin (20 mg/m(2)) was administered every week for 6 weeks with a total dose of 66 Gy of thoracic radiotherapy in 33 fractions. In the consolidation arm, patients were further treated with three cycles of DP (35 mg/m(2) each on days 1 and 8, every 3 weeks). The primary end point was 40% improvement in progression-free survival (PFS) compared with observation. Results From October 2005 to April 2011, 437 patients were randomly assigned. Seventeen patients did not start CCRT as a result of consent withdrawal or ineligibility reasons after random assignment, leaving 420 patients for this analysis (n = 211 for observation; n = 209 for consolidation). Patient characteristics were similar in both arms. In the consolidation arm, 143 patients (68%) received CC, of whom 88 (62%) completed three planned cycles. The median PFS was 8.1 months in the observation arm and 9.1 months in the consolidation arm (hazard ratio, 0.91; 95% CI, 0.73 to 1.12; P = .36). Median overall survival times were 20.6 and 21.8 months in the observation and consolidation arms, respectively (HR, 0.91; 95% CI, 0.72 to 1.25; P = .44). Conclusion CC with DP after CCRT with weekly DP in LA-NSCLC failed to further prolong PFS. CCRT alone should remain the standard of care. (C) 2015 by American Society of Clinical Oncology
키워드
- 제목
- Multinational Randomized Phase III Trial With or Without Consolidation Chemotherapy Using Docetaxel and Cisplatin After Concurrent Chemoradiation in Inoperable Stage III Non-Small-Cell Lung Cancer: KCSG-LU05-04
- 저자
- Ahn, Jin Seok; Ahn, Yong Chan; Kim, Joo-Hang; Lee, Chang Geol; Cho, Eun Kyung; Lee, Kyu Chan; Chen, Ming; Kim, Dong-Wan; Kim, Hoon-Kyo; Min, Young Joo; Kang, Jin-Hyoung; Choi, Jin-Hyuck; Kim, Sang-We; Zhu, Guangying; Wu, Yi-Long; Kim, Sung Rok; Lee, Kyung Hee; Song, Hong Suk; Choi, Yoon-La; Sun, Jong-Mu; Jung, Sin-Ho; Ahn, Myung-Ju; Park, Keunchil
- 발행일
- 2015-08-20
- 유형
- Article
- 권
- 33
- 호
- 24
- 페이지
- 2660 ~ U124
- 언어
- ENG
- 출판사
- American Society of Clinical Oncology
- 발행국가
- 미국
- ISSN
- E 1527-7755
P 0732-183X